# Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008

> **NCT00308438** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 67 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Teduglutide (ALX-0600)

## Key facts

- **NCT ID:** NCT00308438
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03-01
- **Primary completion:** 2005-11-01
- **Final completion:** 2006-06-01
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308438, "Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00308438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*